FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3001596835> ?p ?o ?g. }

• W3001596835 endingPage "111" @default.
• W3001596835 startingPage "103" @default.
• W3001596835 abstract "To determine the effect of oral Glutamine powder supplement in reducing radiation/chemoirradiation induced oral mucositis in patients with Head and Neck malignancies Design and Methodology: An open-label single-blind randomized controlled trial was conducted. Arm A - Radiotherapy/Chemoirradiation who were randomized to receive oral Glutamine powder supplement in addition to the regular oral care protocol. Arm B - Radiotherapy/Chemoirradiation who were randomized to receive regular oral care protocol only without Glutamine supplement. Results: Forty-eight patients were accrued in the trial, 24 in the control arm and 24 in the study arm. All patients completed the treatment protocol except 4 patients in a control group who discontinued treatment after 4 to 5 weeks. The number of patients in the control Vs study arm of the Chemoirradiation group was 16 Vs 15 and in Radiotherapy group 8 Vs 9 patients. The occurrence of Grade 3 mucositis was less in the control arm 30% Vs 40% but the onset was later among patients in the study arm (week3). In the Chemoirradiation group requirement for analgesic (92.8% Vs 53.8%), topical anaesthetic(35.7% Vs 7.6% - significant), occurrence of mouth pain(28.5% Vs 15.3%) and Ryles tube feeding (28.5%vs15.3%) were less in the study arm and also tolerated more number of cycles of concurrent chemotherapy (76% Vs 14% p= 0.036). The number of patients having a break in treatment (0% Vs 42.8% -significant) and occurrence of oral thrush (16% Vs 28.5%) was more in the study arm of Radiotherapy only group but the number of patients included was small (6 Vs 7). Nausea and vomiting was the predominant complaint in study arm probably induced by the study mouth wash. The occurrence of dryness of oral mucosa and throat was more in the study arm of the chemoirradiation group but less in radiotherapy only group. Inference: Overall the addition of oral Glutamine powder supplement along with oral care protocol during treatment did not show significant benefit. But there seems to be some benefit with the use of study mouth wash in the chemoirradiation group only. Since the sample size is small will need to do the study with larger numbers to document statistically significant benefit" @default.
• W3001596835 created "2020-01-30" @default.
• W3001596835 creator A5026405560 @default.
• W3001596835 creator A5057578867 @default.
• W3001596835 date "2020-01-21" @default.
• W3001596835 modified "2023-09-27" @default.
• W3001596835 title "Role of oral glutamine in reducing the severity of radiation induced oral mucositis – A prospective randomized study" @default.
• W3001596835 hasPublicationYear "2020" @default.
• W3001596835 type Work @default.
• W3001596835 sameAs 3001596835 @default.
• W3001596835 citedByCount "0" @default.
• W3001596835 crossrefType "journal-article" @default.
• W3001596835 hasAuthorship W3001596835A5026405560 @default.
• W3001596835 hasAuthorship W3001596835A5057578867 @default.
• W3001596835 hasConcept C126322002 @default.
• W3001596835 hasConcept C141071460 @default.
• W3001596835 hasConcept C168563851 @default.
• W3001596835 hasConcept C2776694085 @default.
• W3001596835 hasConcept C2778496288 @default.
• W3001596835 hasConcept C42219234 @default.
• W3001596835 hasConcept C509974204 @default.
• W3001596835 hasConcept C71924100 @default.
• W3001596835 hasConceptScore W3001596835C126322002 @default.
• W3001596835 hasConceptScore W3001596835C141071460 @default.
• W3001596835 hasConceptScore W3001596835C168563851 @default.
• W3001596835 hasConceptScore W3001596835C2776694085 @default.
• W3001596835 hasConceptScore W3001596835C2778496288 @default.
• W3001596835 hasConceptScore W3001596835C42219234 @default.
• W3001596835 hasConceptScore W3001596835C509974204 @default.
• W3001596835 hasConceptScore W3001596835C71924100 @default.
• W3001596835 hasIssue "1" @default.
• W3001596835 hasLocation W30015968351 @default.
• W3001596835 hasOpenAccess W3001596835 @default.
• W3001596835 hasPrimaryLocation W30015968351 @default.
• W3001596835 hasRelatedWork W2035047172 @default.
• W3001596835 hasRelatedWork W2049835536 @default.
• W3001596835 hasRelatedWork W2348401065 @default.
• W3001596835 hasRelatedWork W2352481176 @default.
• W3001596835 hasRelatedWork W2378991579 @default.
• W3001596835 hasRelatedWork W2382378814 @default.
• W3001596835 hasRelatedWork W2395422105 @default.
• W3001596835 hasRelatedWork W2780866061 @default.
• W3001596835 hasRelatedWork W2799735892 @default.
• W3001596835 hasRelatedWork W2899065112 @default.
• W3001596835 hasRelatedWork W2977476692 @default.
• W3001596835 hasRelatedWork W2994530383 @default.
• W3001596835 hasRelatedWork W2994712634 @default.
• W3001596835 hasRelatedWork W3032058397 @default.
• W3001596835 hasRelatedWork W3044962643 @default.
• W3001596835 hasRelatedWork W3045815489 @default.
• W3001596835 hasRelatedWork W3124198345 @default.
• W3001596835 hasRelatedWork W3177024342 @default.
• W3001596835 hasRelatedWork W3194153002 @default.
• W3001596835 hasRelatedWork W2183515241 @default.
• W3001596835 hasVolume "6" @default.
• W3001596835 isParatext "false" @default.
• W3001596835 isRetracted "false" @default.
• W3001596835 magId "3001596835" @default.
• W3001596835 workType "article" @default.